In addition, Fengbaisan treatment promoted SIRT1 expression, and inhibited the expression of TIMP-1/MMP-9, CHOP, caspase-12 and caspase-3 in COPD rats. This evidence concerns the gene CASP12 and chronic obstructive pulmonary disease.